The Amara Metabolic Reset.
Where modern medicine meets metabolic safety, feminine physiology, and whole-body healing.
Created for Women Who Have Tried Everything…
… and still feel like their metabolism is fighting them.
Women today are exhausted by:
Losing and regaining the same weight
Confusion around hormones
Being told to “eat less and move more”
Trying GLP-1 meds without support
Not knowing what’s actually going on in their body
Feeling hungry, inflamed, or fatigued
Doctors dismissing their symptoms
You deserve a program that finally combines science, safety, hormones, and personalization.
And that’s exactly why The Amara Metabolic Reset™ exists.
👉 100% Virtual
👉 Clinically guided
👉 Premium experience
👉 Shockingly affordable
👉 Designed for women 30+ with real-life demands
What’s Included in Your 4-Month Metabolic Reset
Your enrollment includes complete guidance, supervision, and access for the full 4-month transformation:
You receive:
Initial virtual consultation
Personalized GLP-1, Peptide and Medication planning
Personalized diet, movement and supplement planning
Medication adjustments as you progress
30-day follow-up visit (virtual)
60-day follow-up visit (virtual)
120-day final review (virtual)
Upgrade Your Results With Precision Peptides
Prescription-Only Enhancements From Licensed Providers & FDA-Approved Pharmacies
These optional add-ons are not required, but many clients choose them to accelerate fat loss, improve energy, enhance metabolic flexibility, and optimize long-term health.
Every option below is:
✔ Prescribed by licensed medical providers
✔ Medically supervised as part of your individualized plan
✔ Sourced exclusively from FDA-approved, U.S.-based pharmacies
✔ Reviewed for safety and eligibility through a formal health intake
✔ Integrated with your 4-Month Metabolic Reset
Our medical team determines candidacy, dosing, and safety, and you receive a personalized plan overseen by licensed professionals.
GLP-1 & Triple-Agonist
Semaglutide (GLP-1)
-
Starting at $140/mo (starting dose)
-
Supports appetite regulation and earlier satiety
Improves post-meal glucose control and insulin response
Clinically significant weight reduction in obesity
-
A well-established GLP-1 option with robust data for weight management and cardiometabolic support. Many clients prefer semaglutide as a “slower, steadier” on-ramp into GLP-1 therapy.
-
FDA-approved for select indications
Prescribed by licensed clinicians after full intake review
Compounded and dispensed via 503A compounding pharmacies
Requires ongoing clinical monitoring for GI tolerance and cardiometabolic safety
-
Therapeutic peptides: current applications and future directions
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
GIP and GLP‐1, the two incretin hormones: Similarities and differences
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
The role of glucagon-like peptide 1 (GLP-1) in addictive disorders
Tirzepatide (GLP-1 + GIP Dual Agonist)
-
starting at $205 / month (starting dose)
-
More potent appetite suppression than many single GLP-1 agents
Increases metabolic rate and fat oxidation
Improves insulin sensitivity and glycemic control
Excellent option for metabolic resistance and prior GLP-1 plateaus
-
Clients who have “tried everything” or plateaued on other medications often choose tirzepatide for its stronger body-composition and metabolic effects.
-
FDA-approved for specific indications; used as part of comprehensive metabolic care
Physician determines if dual-agonist therapy is appropriate based on labs and history
Medical supervision required due to potency and dose titration
Compounded/dispensed via 503A compounding pharmacies
-
Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonist, in type 2 diabetes
Mechanisms of action and therapeutic applications of GLP-1 receptor agonists
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
Body composition changes during weight reduction with tirzepatide: SURMOUNT-1 DEXA substudy
The Effect of Tirzepatide on Body Composition in People with Type 2 Diabetes
Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review
Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis
Effect of tirzepatide on leptin and adiponectin levels
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis (SYNERGY-NASH)
Consistent improvements in liver histology across tirzepatide doses in SYNERGY-NASH
Tirzepatide adds hepatoprotection to its armoury
Tirzepatide in metabolic dysfunction-associated steatotic liver disease (MASLD)
Cardiovascular outcomes with tirzepatide: observational meta-analysis of SURPASS trials
Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial (SURPASS-CVOT)
Renal effects of GLP-1 receptor agonists and tirzepatide in type 2 diabetes
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide
Tirzepatide in obstructive sleep apnea (OSA)
Tirzepatide in metabolic dysfunction–associated steatotic liver disease and adipokine modulation
Retatrutide (GLP-1 + GIP + Glucagon Triple Agonist)
-
$306 / month for starting dose.
-
Powerful appetite regulation
Strong thermogenic and fat-burning effects via glucagon pathway
Significant reductions in body weight and improvement in metabolic markers in trials
-
Positioned as a “next-generation” option for highly resistant cases, retatrutide is for clients who want the most aggressive medical approach under close supervision.
-
Currently in late-stage clinical development; regulatory status is evolving
Only appropriate in carefully selected clients under specialist care
Compounded via 503A compounding pharmacies and physician prescription
-
Triple–Hormone-Receptor Agonist Retatrutide for Obesity (mechanism + phase 2)
Triple Agonism–Based Therapies for Obesity (includes retatrutide)
Retatrutide—A Game Changer in Obesity Pharmacotherapy
Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Balanced Activities
GLP-1, GIP, Glucagon Multi-Agonists Review (includes retatrutide)
Phase 2 Trial – Triple–Hormone-Receptor Agonist Retatrutide for Obesity
NEJM “Quick Take” / summary of Phase 2 Trial
Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide
Next-generation Lilly weight-loss drug shows added heart, liver benefits
Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease
GLP-1 Agonists in the Treatment of Chronic Kidney Disease
ESC 2024: Retatrutide Improves Lipid and Cardiovascular Risk Profile in Phase II
-
Glucose (Blood)
Hemoglobin A1c
eAG
Insulin
Leptin
-
hsCRP
-
Estimated GFR
Creatinine
BUN
BUN/Creatinine Ratio
-
Albumin
Phosphate
Folate
Vitamin B12
Vitamin D (25-OH, Total)
-
Iron, Total
Iron % Saturation
Total Iron Binding Capacity (TIBC)
Unsaturated Iron Binding Capacity
Hemoglobin
Hematocrit
MCH
MCHC
MCV
RDW
-
Total Cholesterol
HDL Cholesterol
LDL (Calculated)
Triglycerides
VLDL
Apolipoprotein B
-
Sodium
Potassium
Chloride
Carbon Dioxide
Calcium
-
Estradiol
Testosterone (Total)
SHBG
DHEA-S
Cortisol, Total
-
WBC
RBC
Platelet Count
Although this is our basic panel, this is one of the most comprehensive metabolic panels available for women — normally $600–$900+ in functional medicine practices. We offer it for $350, because our mission is accessibility + accuracy.
Mitochondrial & Longevity
MOTS-c (Mitochondrial Optimization Peptide)
-
$220 / month
-
Supports mitochondrial function and cellular energy
May improve insulin sensitivity and metabolic flexibility in preclinical data
Often used to combat fatigue, plateaus, and poor exercise tolerance during weight-loss phases
-
A favorite for clients on GLP-1s who want better energy, performance, and metabolism support while losing weight.
-
Physician-directed dosing (commonly 2–3x/week) with monitoring of metabolic markers
Dispensed via 503A compounding pharmacies under prescription
-
NAD+ (Injectable or Sublingual)
-
$280 / month
-
Supports cellular energy (ATP) and mitochondrial function
Involved in DNA repair and longevity pathways (sirtuins, PARPs)
May improve fatigue, brain fog, and metabolic function in some individuals
-
NAD+ is a go-to “cellular energy” and longevity support for clients feeling depleted, burned out, or focused on healthy aging.
-
Dosing strategy and route selected by the prescribing clinician
Sourced and prepared via 503A compounding pharmacies
-
GHK-Cu RO 50 mg / GHK-Cu (Copper Peptide)
-
$280 / month
-
Supports skin repair, firmness, and elasticity
May promote hair density and scalp health
Antioxidant and anti-inflammatory signaling at the tissue level
-
Popular for “inside-out” skin and hair support as part of a longevity- and aesthetics-oriented plan.
-
When used as a compounded injectable or capsule, it must be prescribed and filled via 503A compounding pharmacies
Human data focuses largely on skin/hair
-
CJC-1295 + Ipamorelin (GH Stimulation Peptide)
-
$358.75 / month for starting dose.
-
Stimulates pulsatile growth hormone release
Supports muscle recovery, body composition, and sleep quality
May indirectly support fat loss and lean mass preservation
-
Chosen by clients who are strength-training and want better recovery and body-composition support, especially while in a calorie deficit or on GLP-1s.
-
GH axis manipulation requires careful screening (e.g., cancer history, diabetes risk)
Prescribed and filled via 503A compounding pharmacies with ongoing lab monitoring
Not suitable for clients with active malignancy or uncontrolled diabetes
-
Tesamorelin
-
$140 / month for starting dose.
-
↓ appetite and cravings
↓ gastric emptying (feel fuller longer)
↑ insulin response & blood sugar control
Supports steady sustainable fat loss
-
A gentle, effective starting point for GLP-1 therapy. Ideal for women with insulin resistance, PCOS patterns, or emotional eating tendencies.
-
Requires physician approval after reviewing your intake
Dispensed through FDA-approved pharmacies
All dosing + side effect monitoring handled by our medical team
-
The Amara Metabolic (Basic Panel)
BPC-157 (Body Protection Compound)
-
$323.75 / month
-
Support for tissue healing (tendon, ligament, muscle)
May modulate inflammation and angiogenesis in preclinical models
For joint discomfort, overuse injuries, and gut support (off-label/experimental)
-
Chosen by active clients or those with chronic aches who are looking for regenerative-leaning support under medical supervision.
-
Sourced via prescription from 503A compounding pharmacies
-
Your Investment
Program Fee (Covers All 4 Months of Care): $497
This includes every virtual visit, every check-in, every dose adjustment, and all messaging support. There are no surprise fees and no long-term commitments beyond month-to-month recommended medication.
GLOW (GHK-Cu / BPC-157 / TB-500 – 27 mg Blend)
-
$280 / month
-
Combines copper peptide–based skin/hair support with two regenerative-leaning peptides
Aims to support soft-tissue recovery, joint comfort, and overall tissue repair
Often positioned as a “beauty + recovery” blend
-
Clients want a single, simplified formula that supports aesthetics (skin/hair) and joint or tissue recovery.
-
Must be prescribed and dispensed via 503A compounding pharmacies with clear informed consent
Not appropriate for pregnancy, breastfeeding, or clients with active malignancy unless specialist-cleared
-
See studies listed under BPC 157, GHK-Cu, TB-500 Sections
Your Investment
Program Fee (Covers All 4 Months of Care): $497
This includes every virtual visit, every check-in, every dose adjustment, and all messaging support. There are no surprise fees and no long-term commitments beyond month-to-month medication.
⭐️⭐️⭐️⭐️⭐️
“This is the first time in years I’ve lost weight without feeling like I was fighting my own body.”
— Jessica P.
“I’ve been on every diet, every plan, every protocol. Nothing ever felt sustainable. With Amara, the hunger finally disappeared, the inflammation dropped, and I’ve lost 18 lbs in 12 weeks — but more importantly, I feel normal again.”
⭐️⭐️⭐️⭐️⭐️
“My cravings vanished and my energy came back within the first two weeks.”
— Lauren S.
“I didn’t realize how much my hormones were affecting my metabolism. We walked me through exactly what was happening in my body. I feel like I finally understand myself more.”
⭐️⭐️⭐️⭐️⭐️
“I wasn’t just handed a prescription. I was supported, educated, and encouraged the entire time.”
— Amanda H.
“This wasn’t a quick ‘weight loss clinic.’ It felt like a partnership. They helped adjust my dose, helped with side effects, and made sure I never felt alone.”
Ready to Begin Your Reset?
You start with a free virtual consultation — a supportive conversation to see if the program is the right fit for your body and goals.
Click below to reserve your spot. Limited openings each week.